Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9500)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2018 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cho WH, Lee HJ, Bang KB, Kim SB, Song IH. Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-naïve chronic hepatitis B: A case report and review of the literature. World J Gastroenterol 2018; 24(17): 1919-1924 [PMID: PMC5937209 DOI: 10.3748/wjg.v24.i17.1919] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i17/1919.htm |
| Number | Citing Articles |
| 1 |
Ka Wang Cheung, Ying Rong Li, Ms Tiffany Sin-Tung Au, Mimi Tin Yan Seto. Accelerating the momentum to achieve global elimination of hepatitis B infection: a scoping review of hepatitis B guidelines to reduce mother to child transmission. eClinicalMedicine 2025; 80: 103038 doi: 10.1016/j.eclinm.2024.103038
|
| 2 |
Ruochan Chen, Siya Pei, Yayu Chen, Linxia Tan, Ying Xue, Shao Liu, Yan Huang, Xuegong Fan. Suboptimal Response to Tenofovir Alafenamide in Two Patients With HBeAg-Positive Hepatitis B: A Case Report. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.701061
|
| 3 |
Jolynne Mokaya, Anna L. McNaughton, Phillip A Bester, Dominique Goedhals, Eleanor Barnes, Brian D Marsden, Philippa C. Matthews. Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms. Wellcome Open Research 2020; 5: 151 doi: 10.12688/wellcomeopenres.15992.1
|
| 4 |
Chien-Yu Chen, Christina Hajinicolaou, Priya Walabh, Luicer Anne Olubayo Ingasia, Ernest Song, Anna Kramvis. Molecular characterization of hepatitis B virus (HBV) isolated from a pediatric case of acute lymphoid leukemia, with a delayed response to antiviral treatment: a case report. BMC Pediatrics 2022; 22(1) doi: 10.1186/s12887-022-03204-6
|
| 5 |
Helen L Zhang, Meredith Mock, Lane Bushman, Peter L Anderson, Jennifer J Kiser, Susanna Naggie. Cumulative Tenofovir Exposure Among Patients With HIV/Hepatitis B Coinfection With Differential Viral Suppression. Clinical Infectious Diseases 2024; 79(3): 705 doi: 10.1093/cid/ciae241
|
| 6 |
Mauro Viganò, Alessandro Loglio, Pietro Lampertico. Long-term Outcomes in Patients with HBV Treated with Antiviral Agents. Current Hepatology Reports 2018; 17(4): 502 doi: 10.1007/s11901-018-0440-8
|
| 7 |
Zaid H. Tafesh, Robert S. Brown. Management of Virologic Failure in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogues. Current Hepatology Reports 2019; 18(3): 363 doi: 10.1007/s11901-019-00483-z
|
| 8 |
|
| 9 |
Shivali S. Joshi, Carla S. Coffin. Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics. Hepatology Communications 2020; 4(2): 157 doi: 10.1002/hep4.1460
|
| 10 |
Steven M Heaton. Harnessing host–virus evolution in antiviral therapy and immunotherapy. Clinical & Translational Immunology 2019; 8(7) doi: 10.1002/cti2.1067
|
| 11 |
Amir M Mohareb, Joseph Larmarange, Arthur Y Kim, Patrick A Coffie, Menan Gérard Kouamé, Anders Boyd, Kenneth A Freedberg, Emily P Hyle. Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B. The Lancet HIV 2022; 9(8): e585 doi: 10.1016/S2352-3018(22)00123-0
|
| 12 |
Eun-Sook Park, Ah Ram Lee, Doo Hyun Kim, Jeong-Hoon Lee, Jeong-Ju Yoo, Sung Hyun Ahn, Heewoo Sim, Soree Park, Hong Seok Kang, Juhee Won, Yea Na Ha, Gu-Choul Shin, So Young Kwon, Yong Kwang Park, Byeong-Sun Choi, Yun Bin Lee, Nakcheol Jeong, Yohan An, Young Seok Ju, Su Jong Yu, Hee Bok Chae, Kyung-Sang Yu, Yoon Jun Kim, Jung-Hwan Yoon, Fabien Zoulim, Kyun-Hwan Kim. Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients. Journal of Hepatology 2019; 70(6): 1093 doi: 10.1016/j.jhep.2019.02.006
|
| 13 |
Golasa Samadi Kochaksaraei, Abdel A. Shaheen, Cynthia H. Seow, Herman W. Barkema, Carla S. Coffin. Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission—A review of maternal and infant outcomes. Liver International 2022; 42(8): 1712 doi: 10.1111/liv.15249
|
| 14 |
KENDRA R. SYLVESTER-ARMSTRONG, PATRICK DUFF. Evidence for Use of Tenofovir in Pregnancy to Prevent Perinatal Transmission of Hepatitis B Infection. Clinical Obstetrics & Gynecology 2019; 62(4): 835 doi: 10.1097/GRF.0000000000000438
|
| 15 |
Huimin Fan, Luping Lin, Shijie Jia, Min Xie, Chun Luo, Xinghua Tan, Ruosu Ying, Yujuan Guan, Feng Li. Interferon alpha treatment leads to a high rate of hepatitis B surface antigen seroconversion in Chinese children with chronic hepatitis B. Journal of Viral Hepatitis 2019; 26(S1): 77 doi: 10.1111/jvh.13165
|
| 16 |
Jolynne Mokaya, Tongai G Maponga, Anna L McNaughton, Marije Van Schalkwyk, Susan Hugo, Joshua B Singer, Vattipally B Sreenu, David Bonsall, Mariateresa de Cesare, Monique Andersson, Shiraaz Gabriel, Jantje Taljaard, Eleanor Barnes, Wolfgang Preiser, Christo Van Rensburg, Philippa C Matthews. Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults. Journal of Clinical Virology 2020; 129: 104548 doi: 10.1016/j.jcv.2020.104548
|
| 17 |
Fumitaka Suzuki, Hitomi Sezaki, Tetsuya Hosaka, Yoshiyuki Suzuki, Shunichiro Fujiyama, Yusuke Kawamura, Norio Akuta, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Rie Mineta, Yukiko Suzuki, Hiromitsu Kumada. Virologic analysis of tenofovir resistance in a patient with chronic hepatitis B experiencing viral breakthrough during combination treatment with tenofovir disoproxil fumarate and entecavir. Hepatology Research 2021; 51(4): 503 doi: 10.1111/hepr.13618
|